<DOC>
	<DOCNO>NCT00041691</DOCNO>
	<brief_summary>The purpose trial determine safety 90Y-hMN14 different dose level treatment residual colorectal cancer follow recent surgery .</brief_summary>
	<brief_title>Safety Study 90Y-hMN14 Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Disease Characteristics : Patients document histologic cytologic diagnosis colon rectal malignancy Patients document status post surgical resection primary cancer metastasis Limited residual disease ( i.e. , CEA serum level &lt; 15 ng/mL negative baseline CT scan , lesion &gt; 1 cm ) Prior/Concurrent Therapy : Patients must complete chemotherapeutic agent , biologic therapy , radiotherapy , investigational therapy cancer , surgical procedure least six week prior study entry . Patients must recuperate surgery toxicity ( result previous therapy ) sufficiently prior study entry Biologic Therapy : Patients receive murine , chimeric , CDRgrafted ( humanize ) , human IgG eligible provide prestudy evaluation demonstrate significant reactivity hMN14 IgG ( i.e. , HAHA ) Radiotherapy : No prior external beam irradiation field include 30 % red marrow . No prior radiation maximal tolerable level critical organ ( e.g. , 3000 cGy liver ; 2000 cGy lung kidney ) Patient Characteristics/ Performance Status : Patients Karnofsky performance status &gt; 70 % Hematopoietic : ANC &gt; /= 1.5 x 10/L ; Hemoglobin &gt; /= 10 g/dL ; Platelets &gt; /= 100 x 10/L Renal : Serum Creatinine &lt; /= 1.5 x ULN Hepatic : Serum Bilirubin &lt; /= 1.5 ULN ; AST ALT &lt; /= 2.5 x ULN ; Alk Phosphatase &lt; /= 2.5 x ULN Cardiovascular : Patients LVEF &gt; /= 50 % require MUGA/2DECHO test Pulmonary : Patients DF FEV1 &gt; /= 60 % require Pulmonary Function Tests Central Nervous System : Patients know metastatic disease CNS exclude . Other : Patients agree use medically effective method contraception period three month treatment period . A pregnancy test preform premenopausal female childbearing potential immediately prior entry study . Patients must understand give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2003</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Colon Cancer</keyword>
	<keyword>Rectal Cancer</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumor</keyword>
</DOC>